CoChat

Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk

Open access
Chuang, Shu-Chun, Fanidi, Anouar, Ueland, Per Magne, Relton, Caroline, Midttun, Øivind, Vollset, Stein Emil, Gunter, Marc J., Seckl, Michael J., Travis, Ruth C., Wareham, Nicholas, Trichopoulou, Antonia, Lagiou, Pagona, Trichopoulos, Dimitrios, Peeters, Petra H.M., Bueno-de-Mesquita, H. Bas, Boeing, Heiner, Wientzek, Angelika, Kuehn, Tilman, Kaaks, Rudolf, Tumino, Rosario, Agnoli, Claudia, Palli, Domenico, Naccarati, Alessio, Aicua, Eva Ardanaz, Sánchez, María-José, Quirós, José Ramón, Chirlaque, María-Dolores, Agudo, Antonio, Johansson, Mikael, Grankvist, Kjell, Boutron-Ruault, Marie-Christine, Clavel-Chapelon, Françoise, Fagherazzi, Guy, Weiderpass, Elisabete, Riboli, Elio, Brennan, Paul J., Vineis, Paolo, Johansson, Mattias · 2014 · Cancer Epidemiology, Biomarkers & Prevention

Published version of a preprint

Cited by 87

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Imbalances in tryptophan metabolism have been linked to cancer-related immune escape and implicated in several cancers, including lung cancer. Methods: We conducted a nested case–control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) that included 893 incident lung cancer cases and 1,748 matched controls. Circulating levels of tryptophan and six of its metabolites were measured and evaluated in relation to lung cancer risk. Results: Tryptophan (Ptrend = 2 × 10−5) and the kynurenine/tryptophan ratio (KTR; Ptrend = 4 × 10−5) were associated with lung cancer risk overall after adjusting for established risk factors. The ORs comparing the fifth and first quintiles (OR5th vs. 1st) were 0.52 [95% confidence interval (CI), 0.37–0.74] for tryptophan and 1.74 (95% CI, 1.24–2.45) for KTR. After adjusting for plasma methionine (available from previous work, which was strongly correlated with tryptophan), the associations of tryptophan (adjusted Ptrend = 0.13) and KTR (Ptrend = 0.009) were substantially attenuated. KTR was positively associated with squamous cell carcinoma, the OR5th vs. 1st being 2.83 (95% CI, 1.62–4.94, Ptrend = 3 × 10−5) that was only marginally affected by adjusting for methionine. Conclusions: This study indicates that biomarkers of tryptophan metabolism are associated with subsequent lung cancer risk. Although this result would seem consistent with the immune system having a role in lung cancer development, the overall associations were dependent on methionine, and further studies are warranted to further elucidate the importance of these metabolites in lung cancer etiology. Impact: This is the first prospective study investigating the tryptophan pathway in relation to lung cancer risk. Cancer Epidemiol Biomarkers Prev; 23(3); 461–8. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-13-0770

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 37

  1. Jemal, 2011, Global cancer statistics, CA: Cancer J Clin, 61, 69
  2. Ferlay, 2010, Estimates of cancer incidence and mortality in Europe in 2008, Eur J Cancer, 46, 765, 10.1016/j.ejca.2009.12.014 · DOI · Paper page
  3. Sant, 2009, EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary, Eur J Cancer, 45, 931, 10.1016/j.ejca.2008.11.018 · DOI · Paper page
  4. Barbone, 1997, Cigarette smoking and histologic type of lung cancer in men, Chest, 112, 1474, 10.1378/chest.112.6.1474 · DOI
  5. Lyon, 2011, Tryptophan degradation in women with breast cancer: a pilot study, BMC Res Notes, 4, 156, 10.1186/1756-0500-4-156 · DOI
  6. Topalian, 2011, Cancer immunotherapy comes of age, J Clin Oncol: official journal of the American Society of Clinical Oncology, 29, 4828, 10.1200/JCO.2011.38.0899 · DOI · Paper page
  7. Prendergast, 2011, Cancer: Why tumours eat tryptophan, Nature, 478, 192, 10.1038/478192a · DOI
  8. Engin, 2010, Increased tryptophan degradation in patients with bronchus carcinoma, Eur J Cancer Care, 19, 803, 10.1111/j.1365-2354.2009.01122.x · DOI
  9. Le Floc'h, 2011, Tryptophan metabolism, from nutrition to potential therapeutic applications, Amino Acids, 41, 1195, 10.1007/s00726-010-0752-7 · DOI · Paper page
  10. Prendergast, 2008, Immune escape as a fundamental trait of cancer: focus on IDO, Oncogene, 27, 3889, 10.1038/onc.2008.35 · DOI · Paper page
  11. Kolodziej, 2011, Kynurenine metabolism in health and disease, Amino Acids, 41, 1173, 10.1007/s00726-010-0787-9 · DOI
  12. Hecht, 2003, Tobacco carcinogens, their biomarkers and tobacco-induced cancer, Nat Rev Cancer, 3, 733, 10.1038/nrc1190 · DOI · Paper page
  13. Karanikas, 2007, Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer, Cancer Biol Ther, 6, 1258, 10.4161/cbt.6.8.4446 · DOI
  14. Suzuki, 2010, Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer, Lung Cancer, 67, 361, 10.1016/j.lungcan.2009.05.001 · DOI · Paper page
  15. Johansson, 2010, Serum B vitamin levels and risk of lung cancer, JAMA, 303, 2377, 10.1001/jama.2010.808 · DOI · Paper page
  16. Ueland, 2007, Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry, Clin Chem Lab Med, 45, 1737, 10.1515/CCLM.2007.339 · DOI
  17. Midttun, 2009, Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry, Rapid Commun Mass Spectrom, 23, 1371, 10.1002/rcm.4013 · DOI · Paper page
  18. Mandi, 2012, The kynurenine system and immunoregulation, J Neural Transm, 119, 197, 10.1007/s00702-011-0681-y · DOI · Paper page
  19. Schroecksnadel, 2005, Tryptophan degradation in patients with gynecological cancer correlates with immune activation, Cancer Letters, 223, 323, 10.1016/j.canlet.2004.10.033 · DOI
  20. Burns, 2011, Do changes in cigarette design influence the rise in adenocarcinoma of the lung, Cancer Causes & Control: CCC, 22, 13, 10.1007/s10552-010-9660-0 · DOI
  21. Thun, 1997, Cigarette smoking and changes in the histopathology of lung cancer, J Natl Cancer Inst, 89, 1580, 10.1093/jnci/89.21.1580 · DOI · Paper page
  22. Chaturvedi, 2010, C-reactive protein and risk of lung cancer, J Clin Oncol, 28, 2719, 10.1200/JCO.2009.27.0454 · DOI · Paper page
  23. Pine, 2011, Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer, J Natl Cancer Inst, 103, 1112, 10.1093/jnci/djr216 · DOI · Paper page
  24. Hustad, 2012, Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism, Clin Chem, 58, 402, 10.1373/clinchem.2011.174490 · DOI · Paper page
  25. Midttun, 2011, Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation, J Nutr, 141, 611, 10.3945/jn.110.133082 · DOI
  26. Darlington, 2010, On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio, Int J Tryptophan Res, 3, 51, 10.4137/IJTR.S4282 · DOI · Paper page
  27. Frick, 2004, Increasing production of homocysteine and neopterin and degradation of tryptophan with older age, Clin Biochem, 37, 684, 10.1016/j.clinbiochem.2004.02.007 · DOI · Paper page
  28. Ledochowski, 1999, Association between insulin resistance, body mass and neopterin concentrations, Clin Chim Acta, 282, 115, 10.1016/S0009-8981(99)00019-4 · DOI
  29. Oxenkrug, 2010, Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism, Ann N Y Acad Sci, 1199, 1, 10.1111/j.1749-6632.2009.05356.x · DOI · Paper page
  30. Ozkan, 2012, Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients, Clin Rheumatol, 31, 29, 10.1007/s10067-011-1767-5 · DOI
  31. Spencer, 2010, Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat, J Gerontol A Biol Sci Med Sci, 65, 858, 10.1093/gerona/glq066 · DOI
  32. Oxenkrug, 2011, Interferon-gamma - inducible inflammation: contribution to aging and aging-associated psychiatric disorders, Aging and Dis, 2, 474
  33. Oxenkrug, 2011, Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders, J Neural Transm, 118, 75, 10.1007/s00702-010-0475-7 · DOI · Paper page
  34. Sakakeeny, 2012, Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults, J Nutr, 142, 1280, 10.3945/jn.111.153056 · DOI
  35. Pertovaara, 2006, The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers, Clin Exp Immunol, 145, 469, 10.1111/j.1365-2249.2006.03166.x · DOI
  36. Stampfli, 2009, How cigarette smoke skews immune responses to promote infection, lung disease and cancer, Nat Rev Immunol, 9, 377, 10.1038/nri2530 · DOI · Paper page
  37. Nawashiro, 2006, L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors, Int J Cancer, 119, 484, 10.1002/ijc.21866 · DOI · Paper page

Cited by

See all 87

Metadata

Authors
Chuang, S.-C., Fanidi, A., Ueland, P. M., Relton, C., Midttun, Ø., Vollset, S. E., Gunter, M. J., Seckl, M. J., Travis, R. C., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H. M., Bueno-de-Mesquita, H. B., Boeing, H., Wientzek, A., Kuehn, T., Kaaks, R., Tumino, R., Agnoli, C., Palli, D., Naccarati, A., Aicua, E. A., Sánchez, M.-J., Quirós, J. R., Chirlaque, M.-D., Agudo, A., Johansson, M., Grankvist, K., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Fagherazzi, G., Weiderpass, E., Riboli, E., Brennan, P. J., Vineis, P., & Johansson, M.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2014-03-01
Volume
23
Issue
3
Pages
461-468
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2145635515
Cited by
87
References
5
FWCI
0.93
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk. https://app.cochat.ai/papers/10.1158/1055-9965.epi-13-0770
The paper
Chuang, S.-C., Fanidi, A., Ueland, P. M., Relton, C., Midttun, Ø., Vollset, S. E., Gunter, M. J., Seckl, M. J., Travis, R. C., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H. M., Bueno-de-Mesquita, H. B., Boeing, H., Wientzek, A., Kuehn, T., Kaaks, R., . . . Johansson, M. (2014). Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-13-0770

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.